Explore Yeast Nanobody Library for Advanced Research and Development

Discover the power of innovation with our Yeast Nanobody Library, brought to you by the leading biotechnology company Alpha Lifetech Incorporation. Our cutting-edge library offers a diverse collection of high-quality Nanobodies, providing researchers with a powerful tool for drug discovery, diagnostics, and therapeutics development, Derived from yeast, our nanobody library offers superior stability and solubility, making it an ideal platform for the isolation of nanobodies with high affinity and specificity. With our comprehensive collection, researchers can access a wide range of targets, accelerating the process of identifying and developing novel biologics, At Alpha Lifetech Incorporation, we are committed to advancing scientific research and empowering the biotech community with innovative solutions. Our Yeast Nanobody Library is designed to streamline the nanobody discovery process, ultimately driving progress in the fields of medicine, biotechnology, and beyond. Join us in revolutionizing the way nanobodies are discovered and developed with our state-of-the-art library

Hot Selling Product

ALP64667-Recombinant Human CD276/B7-H3 Protein, His Tag

ALP64601-Recombinant Rabbit CD80/B7-1 Protein, His Tag

ADT1353-Lesofavumab Biosimilar-(Influenza B virus hemagglutinin)-Research Biosimilar Antibody

ADT1618-Tadocizumab Biosimilar-Anti-ITGA2B_ITGB3 mAb-Research Grade

ADT1653-Timigutuzumab Biosimilar-Anti-ERBB2/EGFR2/CD340 mAb-Research Grade

ADT1471-Oportuzumab Monatox Biosimilar-Anti-EPCAM/CD326 mAb-Research Grade

Today's Choice of Yeast Nanobody Library Service Where Innovation Meets 2025

In the ever-evolving landscape of biotechnology, Alpha Lifetech Inc. stands at the forefront, offering innovative solutions that cater to diverse research needs. As we approach 2025, the demand for efficient and reliable tools in Protein research has surged, and it is here that our expertise shines. Our yeast nanobody library service is designed for researchers seeking high-quality reagents to accelerate their discovery processes. The unique properties of nanobodies make them invaluable in various applications, from therapeutic development to diagnostic tools. Founded by a team of seasoned scientists skilled in membrane protein production and monoclonal development, Alpha Lifetech Inc. is committed to providing unparalleled service and products. With a catalog that boasts nearly 10,000 high-quality spot membrane protein reagents, cytokines, and drug target antibodies, we are equipped to meet the specific needs of global buyers. Our yeast nanobody library service not only exemplifies our commitment to innovation but also ensures that researchers access cutting-edge solutions to enhance their workflows. Join us in pushing the boundaries of science as we pave the way for advanced research in the coming years.

Today's Choice of Yeast Nanobody Library Service Where Innovation Meets 2025

Library Name	Number of Clones	Target Antigen	Application	Additional Features
Yeast Library A	50,000	Influenza Virus Protein	Therapeutic	High Affinity Selection
Yeast Library B	75,000	Cancer Biomarker	Diagnostics	Diversity Enhanced
Yeast Library C	100,000	HIV Envelope Protein	Vaccine Development	Customizable
Yeast Library D	20,000	Cholesterol Transporter	Research	Fast Turnaround
Yeast Library E	30,000	Diabetes Protein	Therapeutics	Robust Screening

Yeast Nanobody Library Utilization: Trends Over the Years

The chart above illustrates the increasing trend in the utilization of Yeast Nanobody Library Service from 2019 to 2023. As the data shows, there has been a steady rise in the percentage of services utilized year over year. In 2019, only 20% of researchers and companies made use of this innovative library. However, with growing interest in biotechnology and therapeutic applications of nanobodies, the utilization surged to 35% in 2020, 50% in 2021, and so forth, culminating in an impressive 80% utilization rate in 2023. This growth can be attributed to advancements in technology, increased awareness of the potential of nanobodies in various fields, and a broader range of applications emerging. The upward trajectory signifies not only the rising confidence in this technology but also its pivotal role in research and development initiatives in the coming years.